Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Aditxt, Inc.
< Previous
1
2
Next >
Aditxt Announces $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
August 31, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. (NASDAQ: ADTX) Provides Shareholder Update and Planned Strategy for Achieving Commercial Scale
August 18, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
CORRECTING and REPLACING Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on August 18, 2023
August 17, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc.’s Wholly-Owned Subsidiary Pearsanta, Inc. Looks to Expand Customer Base, Payor Access, and Genetic Testing with a Non-Binding Letter of Intent to Acquire Natural State Laboratories and Natural State Genomics
June 20, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Subsidiary Adimune Signs Clinical Trial Agreement with Top Research Institution to Study Stiff Person Syndrome
May 05, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
April 20, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership of Global Response Aid – with Rights to Manufacture and Market Broad-Spectrum Antiviral Drug Avigan
April 20, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Issues Shareholder Update
April 17, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Names Media Industry Veteran Maureen Connolly as Chief Content and Engagement Officer
March 08, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Retains Riverside Management Group as Advisor to Support Strategic M&A Driven Acquisitions by Subsidiary Pearsanta, Inc.
March 03, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Forms its Second Subsidiary, Pearsanta, Inc., to Accelerate the Growth of its AditxtScore™ Program and Appoints Healthcare Executive and Current Head of AditxtScore™ Anthony Voorhies to Serve as its President
February 14, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Forms Adimune, Inc. as a Wholly Owned Subsidiary with a Focus on Immune Modulation Therapies and Appoints Dr. Friedrich Kapp, Former President of the Therapeutic Business Unit at Schering AG, as its Chairman and CEO
January 03, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt’s (Nasdaq: ADTX) Adimune™ Program Has Initiated the Manufacturing Process of Immunotherapeutic Drug Candidate, ADI™-100 in Preparation for Planned Psoriasis First-in-Human Trials
October 21, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. (Nasdaq: ADTX) Announces Development and Publication of a Mathematical Model for Predicting Longevity and Variations of Immune Response to Immunization to SARS-CoV-2 Infection
October 12, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
FedEx Features AditxtScore™ Immune Monitoring Center and its Service in Richmond, VA, Highlighting the Importance of Quantifying Immune Health
October 07, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. (NASDAQ: ADTX) Announces That it Has Regained Compliance with Nasdaq Listing Requirements
September 29, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Inc. (Nasdaq: ADTX) Provides Corporate Highlights Post Reverse Stock Split and Closing of $20M Public Offering
September 27, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Announces Closing of $20.0 Million Public Offering
September 20, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. (Nasdaq: ADTX) Announces 1-for-50 Reverse Stock Split Effective Pre-Market Opening on September 14, 2022
September 13, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. Successfully Completes Preclinical Toxicity Study of Its Psoriasis Drug Candidate ADI™-100 Advancing it Closer to First-in-Human Trials
July 08, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. Partners with Guthy-Renker Affiliate GRS to Launch Consumer Awareness Campaign for AditxtScore™ to Accelerate Adoption and Revenue Growth
April 14, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Signs Revenue-Sharing Agreement with Cellvera for up to $30M, and Hosts a Live Business Update Webinar on April 14th
April 05, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt to Participate in the 2022 Virtual Growth Conference
March 23, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Submits Two Requests for Emergency Use Authorization to FDA for AditxtScore™ for COVID-19 Tests Which Measure the Quantity and Quality of Antibodies Against COVID-19 and its Variants Including Omicron
January 18, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference From January 25th-27th, 2022
January 14, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Provides Online Business Update Townhall Meeting with Amro Albanna, Co-Founder & CEO
January 12, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Signs Amendment to Extend Worldwide Licensing Agreement, Granting Exclusivity in all Fields of Use
December 29, 2021
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. Signs Non-Binding Letter of Intent to Acquire Point-of-Care Diagnostic Technology Development Company
December 13, 2021
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Announces Closing of $17.4 Million Firm Commitment Public Offering of Common Stock and Warrants
December 06, 2021
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Extends the Timeline to Sign the Definitive Agreement to Acquire AiPharma Global to December 16, 2021
December 02, 2021
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit